Chromatin immunoprecipitation with sequencing (ChIP-seq) analysis confirmed direct binding of ASCL1 to the promoter region of PROX1, and to enhancer and promoter regions of FOXA2, in both SCLC cell lines (Fig. 5i, j). Here, FOXA2 is linked to small cell lung carcinoma.